Dublin, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The "Expression Vectors - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for Expression Vectors was valued at US$493.2 Million in 2024 and is projected to reach US$677 Million by 2030, growing at a CAGR of 5.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Agilent Technologies Inc., Bio-Rad Laboratories Inc., Clontech Laboratories, Inc. a Takara Bio Company, DNA TwoPointO Inc. (dba ATUM), Merck KGaA and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
What Factors are Driving the Growth of the Expression Vectors Market?
The growth of the expression vectors market is driven by several key factors, including the increasing demand for recombinant proteins, advancements in gene therapy, and the expanding field of synthetic biology. One of the primary drivers is the growing need for recombinant proteins in pharmaceutical manufacturing, particularly for biologics like monoclonal antibodies, vaccines, and therapeutic enzymes. As the demand for biologics continues to rise, so too does the need for reliable and efficient expression systems that can produce these proteins at scale. Expression vectors are central to this process, providing the means to introduce therapeutic genes into host cells that produce the target proteins. With the global biopharmaceutical industry experiencing rapid growth, the demand for high-performance expression vectors is expected to increase.
Advancements in gene therapy are also a significant factor driving the growth of the expression vector market. The development of new gene therapies to treat rare genetic disorders, cancers, and chronic diseases has spurred investment in vector technologies capable of delivering therapeutic genes safely and effectively. Viral vectors, such as adeno-associated viruses (AAVs) and lentiviruses, are at the forefront of gene therapy development, providing the efficiency needed to deliver therapeutic genes to target cells. Additionally, non-viral vectors are gaining traction due to their potential for lower immunogenicity and toxicity. These vectors are being developed to improve the safety and scalability of gene therapies, particularly as the regulatory landscape for gene therapy becomes more established and clinical trials expand. The success of approved gene therapies, such as those for spinal muscular atrophy and certain types of leukemia, has further fueled interest in expression vector technology.
The rise of synthetic biology and its application in industries such as biofuel production, agriculture, and pharmaceuticals is another key factor contributing to the market's growth. Synthetic biology, which involves the design and construction of new biological systems, relies heavily on expression vectors to program cells with novel functions. These vectors are used to introduce synthetic gene circuits into cells, enabling them to produce new compounds, metabolize waste, or even create self-replicating materials. As synthetic biology continues to grow, particularly in the development of sustainable solutions for energy, food, and medicine, the demand for specialized expression vectors will increase. Additionally, government and private sector funding for biotechnology research and development is further accelerating the growth of the expression vector market, providing resources for the continued innovation of vector technologies.
In conclusion, the expression vectors market is poised for significant growth due to the increasing demand for recombinant proteins, advances in gene therapy, and the expanding applications of synthetic biology. As industries ranging from pharmaceuticals to agriculture continue to innovate and push the boundaries of genetic engineering, expression vectors will remain central to the development of new therapies, products, and technologies. With ongoing advancements in vector design, gene regulation, and genome editing, the future of expression vectors holds immense potential for revolutionizing biotechnology and transforming industries across the globe.
Report Scope
The report analyzes the Expression Vectors market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.
Segments
Type (Bacterial Expression Vectors, Mammalian Expression Vectors, Insect Expression Vectors, Yeast Expression Vectors); Application (Therapeutic, Industrial, Research); End-Use (Pharma & Biotech Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic Research Institutes, Other End-Uses).
Geographic Regions/Countries
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Bacterial Expression Vectors segment, which is expected to reach US$362.4 Million by 2030 with a CAGR of a 5.5%. The Mammalian Expression Vectors segment is also set to grow at 5.9% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $135.9 Million in 2024, and China, forecasted to grow at an impressive 5.2% CAGR to reach $106.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Expression Vectors Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Expression Vectors Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Expression Vectors Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Some of the 46 major companies featured in this Expression Vectors market report include:
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Clontech Laboratories Inc. a Takara Bio Company
- DNA TwoPointO Inc. (dba ATUM)
- Merck KGaA
- MilliporeSigma
- New England Biolabs Inc.
- Promega Corporation
- QIAGEN GmbH
- Thermo Fisher Scientific Inc.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 196 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $493.2 Million |
| Forecasted Market Value (USD) by 2030 | $677 Million |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Global |
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Expression Vectors - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
MARKET TRENDS & DRIVERS
- Rising Demand for Recombinant Proteins in Research and Therapeutics Driving Expression Vector Adoption
- Advancements in Gene Therapy and Genetic Engineering Enhancing Vector Development
- Global Expansion of Biopharmaceutical Manufacturing Increasing Vector Demand
- Development of Viral and Non-viral Vectors for Gene Delivery Applications
- Market Response to Growing Interest in Personalized Medicine
- Advancements in Synthetic Biology Driving Novel Vector Constructs
- Impact of Bioinformatics Tools on Vector Design and Function Prediction
- Global Health Initiatives Boosting Research in Vaccines and Gene Therapies
For more information about this report visit https://www.researchandmarkets.com/r/90nozk
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
